Search Results - Martin Schulz
Martin Schulz
Martin Schulz (born 20 December 1955) is a German politician who was a Member of the European Parliament (MEP) from Germany from 1994 to 2017 and a Member of the Bundestag (MdB) from 2017 to 2021. During his tenure he was Leader of the Progressive Alliance of Socialists and Democrats from 2004 to 2012, President of the European Parliament from 2012 to 2017 and Leader of the Social Democratic Party from 2017 to 2018.In November 2016, Schulz announced he would not seek a third term as President of the European Parliament, but instead would stand in 2017 as the SPD candidate for the German Chancellorship. In January 2017, Sigmar Gabriel announced he would not stand for re-election as party leader and as the SPD candidate for the German Chancellorship, Gabriel recommended Schulz as his replacement.
After the elections of September 2017, which resulted in a postwar low for the SPD, Schulz declared the end of the existing Grand coalition under Angela Merkel and explicitly refused to serve in a Merkel government. On 7 February 2018, coalition talks concluded and Schulz announced he would succeed Sigmar Gabriel as Foreign minister and leave his party chairmanship to Andrea Nahles. After heavy public and internal criticism, Schulz decided not to enter the new cabinet. On 13 February 2018 Schulz stepped down as party chair. Provided by Wikipedia
- Showing 1 - 15 results of 15
-
1
-
2
-
3
-
4
Knowledge and attitudes of German and Swiss community pharmacists towards biologicals and biosimilars – a prospective survey before and after the COVID-19 pandemic by Kirstin Messner, Christiane Eickhoff, Martin Schulz, Samuel S. Allemann, Isabelle Arnet
Published in BMC Health Services Research (2023-12-01)Get full text
Article -
5
-
6
-
7
-
8
-
9
Rationale for using centralized transduction inhibition assays in three phase 3 rAAV gene therapy clinical trials by Martin Schulz, George Bashirians, Seng H. Cheng, Daniel I. Levy, Mark Lundie, Lisa Wilcox, Ian Winburn, Suryanarayan Somanathan
Published in Molecular Therapy: Methods & Clinical Development (2023-12-01)Get full text
Article -
10
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany by Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Published in Pharmaceuticals (2020-10-01)Get full text
Article -
11
-
12
Fostering collaboration: a controlled pilot study of interprofessional education for medical and pharmacy students by Maike Petersen, Sabine Gehrke-Beck, Nicole Zimmermann, Amrei-Pauline Konrad, Ronja Behrend, Harm Peters, Martin Schulz, Charlotte Kloft, Wolfram J. Herrmann
Published in BMC Medical Education (2025-06-01)Get full text
Article -
13
Hidden sodium in effervescent-tablet dietary supplements and over-the-counter drugs: a comparative cross-sectional study by Martin Schulz, Ulrich Laufs, Michael Böhm, Christian Ukena, Felix Mahfoud, Michael Kunz, Felix Götzinger, Cathy M Jacobs, Lucas Lauder, Markus R Meyer
Published in BMJ Open (2023-11-01)Get full text
Article -
14
Task sharing in an interprofessional medication management program – a survey of general practitioners and community pharmacists by Robert Moecker, Marina Weissenborn, Anja Klingenberg, Lucas Wirbka, Andreas Fuchs, Christiane Eickhoff, Uta Mueller, Martin Schulz, Petra Kaufmann-Kolle, ARMIN Study Group, Walter E. Haefeli, Hanna M. Seidling
Published in BMC Health Services Research (2022-08-01)Get full text
Article -
15
Strengthening health systems for access to gene therapy in rare genetic disorders by Sonal Bhatia, Yann Le Cam, Juan Carrion, Lauren Diamond, Paul Fennessy, Safiyya Gassman, Felix Gutzwiller, Stephen Kagan, Diana Pankevich, Jennifer Young Maloney, Nitin Mahadev, Martin Schulz, Durhane Wong-Rieger, Paolo Morgese
Published in Molecular Therapy: Methods & Clinical Development (2024-06-01)Get full text
Article